What do pediatric neuro-oncology survivorship patients and caregivers think of telehealth? While convenient, it often comes at a loss of effectiveness and personal connection. Have ideas for improvement? @ischua @DFBC_PedCare@JNeurooncol#survonc
https://t.co/dsxa93IiDi
@sofsandovl I was told by a surgery PGY2 as a peds PGY1 that he would 'ruin my career' because of my lack of subservience. God bless him, he could not.
You are not inferior. You are a participant in a heirarchical, harmful system long due for reckoning.
It's a roller coaster clinic day when upon searching drug information you stumble upon a your cartoon self reminding you to have hope.
Ongoing Research in Brain Tumor Therapies Provides Hope for the Future https://t.co/RzhKLkrwJ3 via @targetedonc
@vickyyyf We're not ok, but we clearly don't deserve anyone's sympathy. Also the brown one is a high femme and the orange one has an anxiety disorder - which I fully support, as this represents the majority of my friends and loved ones.
@jestsai and I also pontificated on @JCO_ASCO's insightful findings for relapsed infant medulloblastoma. Congrats to @craigerkerMD and colleagues, we cannot rest until these children are given cures with hope for lives well lived. https://t.co/TMc4uPo106 via @practiceupdate
pLGG response and rebound depends on driver and drug, but we need much larger studies to crystallize expectations. Grateful to work with these co-authors ❤️. @DFBC_PedCare@jestsai@KeithLigon5 @Bando_Lab
Congrats @jestsai@CooneyTab! Special thanks to @PBTF and @DanaFarber Pediatric Low Grade Astrocytoma Program for amazing support! #astrocytoma
Integrated response analysis of pediatric low-grade gliomas during and after targeted therapy treatment https://t.co/anxd6aqblO
Congrats to @jstraehlaMD, 2022 recipient of the @aacr-Day One Biopharmaceuticals Pediatric Cancer Research Fellowship!
The award will help Dr. Straehla bring new drug delivery technologies to the clinic for children with central nervous system tumors.
https://t.co/Sraskv7Qnh
@DFBC_PedCare alum Andrew Groves has a way with words, beautiful summary of our potential to manipulate epigenetic programming for pediatric high-grade glioma. Time is of the essence. #HGG#braintumor#epigenetics https://t.co/ZWXngwIhNF
🧵Excited to share our manuscript now available online with Neuro-Oncology Advances! https://t.co/DSGXQOdzsw
Integrated response analysis of pediatric low-grade gliomas during and after targeted therapy treatment @EditorNeuro 1/7
@DrSMoerdler Recognize why trainees feel the least empowered; question the mechanisms of our heirarchy. Work to radically change our values ubiquitous throughout academia - team work, delegation, shared goals over individualism, power hoarding.
What a heavy moment to be a queer, academic pediatric neuro-oncologist. So uplifting to feel #SNO2022 representation and community, then shattering to return to violence invoked by rising hate and fear. We Were (And Are) Always Here ✊❤️#LGBTQIA
It has been confirmed that we lost these two beautiful boys in the attack on Club Q. Please know that they were loved and that we are grieving them. We REMEMBER them.
#tdor#clubq
Such power in hearing how @michelle_monje navigated early motherhood - and bias - while building her career; our generation can change the systems that currently support few. Much gratitude to all of our mentors who attended and supported our YIs - the future is bright! #SNO2022
Uplifting session with @michelle_monje, @FransonAndrea, @doctweettweet, @DanielRuncoMD, @CooneyTab, Sabine Mueller, Gene Hwang, & many others - so grateful for their advice as senior clinician-investigators, finding support while navigating life’s ups and downs. #SNO2022
I also appreciated @CooneyTab (and her rainbow flag pin!) introducing @michelle_monje as Dr. Monje (maybe it should have been Dr. Dr. Monje 😂). Again, representation matters!